Temporal effects of various immunosuppressive drugs on the immune response by Swanson, Priscilla Ann
University of Montana 
ScholarWorks at University of Montana 
Graduate Student Theses, Dissertations, & 
Professional Papers Graduate School 
1976 
Temporal effects of various immunosuppressive drugs on the 
immune response 
Priscilla Ann Swanson 
The University of Montana 
Follow this and additional works at: https://scholarworks.umt.edu/etd 
Let us know how access to this document benefits you. 
Recommended Citation 
Swanson, Priscilla Ann, "Temporal effects of various immunosuppressive drugs on the immune response" 
(1976). Graduate Student Theses, Dissertations, & Professional Papers. 6223. 
https://scholarworks.umt.edu/etd/6223 
This Thesis is brought to you for free and open access by the Graduate School at ScholarWorks at University of 
Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an 
authorized administrator of ScholarWorks at University of Montana. For more information, please contact 
scholarworks@mso.umt.edu. 
TEMPORAL EFFECTS OF VARIOUS IMMUNOSUPPRESSIVE DRUGS 
ON THE IMMUNE RESPONSE
by
Priscilla A, Swanson 
B.S., Nebraska Wesleyan University, 1971
Presented in partial fulfillment of the requirements
for the degree of
MASTER OF SCIENCE
UNIVERSITY OF MONTANA
1976
Chairman, Board of^xaminers
Deajvi' Graduate School
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
UMI Number: EP37024
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed.
a note will indicate the deletion.
UMI
DisMrtation Putdnhing
UMI EP37024
Published by ProQuest LLC (2013). Copyright in the Dissertation held by the Author.
Microform Edition ©  ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17. United States Code
uest
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106 - 1346
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Swanson, Priscilla A., M.S. June 1976 Microbiology
Temporal Effects of Various Immunosuppressive Agents on the Immune 
Response (89 pp)
Directors: Richard N. Üshijima and Carl L. Larson
Immunosuppressive agents, those which suppress or prevent various 
phases of the immune response, have been used experimentally to analyze 
the basic cellular and molecular events involved in normal immune 
responses and have been applied clinically during therapeutic pro­
grams for organ transplantation, autoimmune disease, and malignancy.
The immune mechanism encompasses several overlapping stages, primarily 
the afferent arm or induction of immunity and the efferent arm or expres­
sion of immunity. In addition, the immune response consists of two 
distinct cell compartments. Thymus-derived lynqphocytes, T cells, 
differentiate into cells functioning in cellular immunity while bone- 
marrow-derived lynqphocytes, B cells, are activated to produce and 
secrete antibody. With regard to the type of drug, dosage, schedule, 
and route of administration, any of the levels of the Immune response 
are subject to suppression.
In this study four drugs were investigated superficially in an attempt 
to understand the interaction of drugs and the immune response and 
to define the lymphoid cell population(s) most susceptible to suppression. 
Emphasis was placed on hydrocortisone acetate while azathioprine, 
niridazole, and methotrexate were studied in less detail. Immuno­
suppressive effects on induction and expression of cellular immunity 
were accomplished by assaying the delayed hypersensitivity (DH) response 
of drug-treated animals to the chemical sensitizing agent oxazolone. 
Suppression of humoral immune induction was measured by antibody pro­
duction of rabbit red blood cells and by spleen B cell levels assayed by 
immunofluorescence. Subsequent Friend Disease Virus infection of drug- 
treated mice was also used to determine the presence of functional B cells,
Treatment with these four drugs resulted in immune suppression, but 
variations in degree, duration, and susceptible cell populations were 
noted. Hydrocortisone acetate affected both cellular and humoral 
immunity but appeared to have the most profound effect on T cells 
involved in expression of DH and induction of antibody production. 
Azathioprine and niridazole also caused more pronounced suppression 
of T cell rather than B cell function as shown by depression of the 
DH response. However, suppression of DH expression was delayed 
for several days following azathioprine and niridazole treatment 
whereas cortisone suppressed the DH response immediately. Metho­
trexate, on the other hand, suppressed the B-cell compartment of 
the immune response. Cortisone, azathioprine, and niridazole 
appeared to exert their immunosuppressive effect by altering antigen 
recognition,either due to defective antigen receptors or unavailable 
lymphocytes, whereas methotrexate apparently suppressed lymphocyte 
proliferation.
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Chapter 1 
INTRODUCTION
Regulation and control of immune responses occupies a major 
area of scientific research. Agents which suppress or prevent 
immunological responses, i.e. immunosuppressive agents, aid in 
dissecting basic immune mechanisms and are applied clinically 
to transplant recipients and to patients with autoimmune diseases, 
hormonal imbalance, malignancy, and hypersensitivity conditions. The 
effects of these agents range from indiscriminate bombardment of the 
immune mechanisms to specific effects directed at "target areas" (51)• 
An understanding of the mechanisms of action of various chemical 
and physical agents might enable manipulation to remove undesirable 
immune responses without damaging the vital defenses of the host. 
However, it must be kept in mind that immunosuppressive agents are 
as heterogeneous and complex as the immune reactions which are altered, 
although several basic considerations apply to all groups: hetero­
geneity of lymphoid cells, species differences, undesirable sequellae 
of elimination of any component of the immune response, and decreased 
immunosurvei1lance resulting in increased threat of malignancy and 
autoimmune disease.
The immune mechanism consists of several overlapping stages, 
predominantly the processing of antigen or afferent arm and the 
eliciting of the immune response or efferent arm (20), Since immuno-
1
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suppressive agents may alter one or more of these processes, a 
discussion of the immune mechanism follows.
Antigens entering a host are ingested and processed by macro­
phages facilitating immobilization or concentration of these antigens 
for easier access to lymphoid cells. Although the immune system 
is composed of two distinct populations of lymphocytes, these cells 
originate as precursor bone marrow stem cells capable of responding 
to antigen under normal conditions.
One type of lymphocyte is known as thymus-derived or T lymphocyte. 
The stem cells migrate to the thymus gland, develop characteristic 
surface antigens, and differentiate into cells which function in 
cellular immunity. The T lymphocytes are responsible for defense 
against viruses, fungi and intracellular pyogenic bacterial pathogens, 
delayed allergic reactions, and surveillance and destruction of malig­
nant cells. These lymphocytes proliferate in the cortical area of 
the thymus then shift to the medullary region from where they enter 
the circulatory system and peripheral lymphoid tissues as competent 
T cells. During maturation TL isoantigens and the theta isoantigen 
arise on the cell surface (l6). The theta antigen is retained on 
cells throughout their circulation and constitutes a T cell marker. 
Because T cells are continually circulating and recirculating, the 
population may be depleted by such methods as thymectomy, thoracic 
duct drainage, or chemotherapy, which will be important in later 
considerations of immunosuppressive drugs.
The second component of the lymphoid system consists of Bursa- 
equivalent derived cells or B lymphocytes, which differentiate into
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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cells functioning in humoral immunity. Following antigenic stimulation 
through the mediation of a macrophage, B cells differentiate into immuno­
competent plasma cells and produce and secrete immunoglobulins, A 
single clone of B cells secretes only one type of antibody and may 
be identified by its surface immunoglobulin. These cells appear to 
be localized in the medullary cord, central lymphoid follicles, and 
peripheral cortical regions of the lymph nodes, the splenic red pulp 
and peripheral wliite pulp, and the subepithelial lymphoid follicles 
(51). Table 1 gives some characteristics of T and B lymphocytes.
Antibody production for certain antigens requires interactions 
of the T and B-cell compartments. Certain T lymphocytes function as 
"helper” cells and are activated by antigen. These activated T cells 
interact with B cells, which in turn produce circulating antibody,
T cell - B cell cooperation may or may not be required for antibody 
synthesis. Antigens such as endotoxin, pneumococcal polysaccharide, 
and polyvinylpyrrolidone are T cell independent suggesting that B cells 
probably have antigen recognition sites, while sheep red blood cells 
(SRBG) and sérum protein antigens are T cell dependent. Interactions 
of the two components tend to amplify the immune response.
Immunosuppressive drugs are used to study the functions of 
normal and undesirable immune responses. Variations in the type of 
drug, dosage, and route of administration aid in defining and 
dissecting induction and production phases of the immune response, 
delayed hypersensitivity and nonspecific inflammatory responses, 
drug induced immunological tolerance, and homograft rejection. 
Manipulation of induction and production of the immune response leads
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 1. Comparison of T and B lymphocytes (9).
Properties B cells T cells
Tissue origin
Cell surface antigen
Antigen receptors
Hapten-antigen 
recognition
Tissue distribution
Functions
Complement receptors 
Mitogen susceptibility
Steroid susceptibility
X-irradiation
susceptibility
Tolerance
Bursa of Fabricius 
(in birds) or bone 
marrow
H-2 transplantation 
antigen
Surface immunoglo­
bulins
To hapten
High in spleen, 
low in lymphatic 
tissue and blood
Secretion of 
antibody
Binds C3 
Pokeweed
Li popolysaccharide
Resistant
Sensitive
Occurs late, of 
short duration
Thymus
Theta
TL
Unknown
To carrier 
antigens
High in thoracic 
duct, lymph nodes, 
and blood .
Helper function, 
effector cell for 
cell-mediated immunity
None known
Phytohemagglutinin 
Gonconavoline A 
Pokeweed
Sensitive
Resistant
Occurs early, persists
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to an understanding of the multicellular nature of antibody 
responses and the differential susceptibility of different cell 
populations to drug treatment.
The inductive phase of tlie antibody response is that time between 
contact of antigen with the host and antibody production. Since 
low levels of antibody may be beyond detection, the presence of an 
inductive phase was questioned, Sterzl (8?) injected newborn 
rabbits with spleen cells and antigen. When administering 6-mercap- 
topurine (6-WP), which substitutes for purines in nucleic acids, with 
or shortly following the spleen cell transfer, he noted a marked 
decrease in antibody production. If donor plasma cells secreting 
antibody were used, suppression did not occur, suggesting that the 
drug interferes with nucleic acid synthesis in uncommitted lymphocytes, 
Gnotobiotic piglets injected with SRBG*s and actinomycin D, which 
binds to guanine residues, also show no antibody production, whereas 
control animals develop antibodies in three days (88), Therefore, 
induction of antibody formation probably depends on RNA synthesis 
leading to mitosis. In two classic studies by Berenbaum (ll, 12) 
irradiation or busulfan given prior to antigenic stimulation inhibited 
antibody response to TAB (typhoid - paratyphoid A and B) vaccine in 
mice whereas methotrexate (MTX), 6-MP, 6-thioguanine (6-TG), or 
nitrogen mustard inhibited the response if given following the anti­
genic stimulation. Evidently, immunocompetent cells are sensitive 
to irradiation and busulfan but become susceptible to other immuno­
suppressive drugs when differentiated to immunoblasts.
During the productive phase of the primary immune response
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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when antibody is being secreted, cells are proliferating and mRNA 
is being produced. When cells in this phase are exposed to metabolic 
inhibitors, replication is blocked but antibody production is not 
significantly depressed (89). Sterzl (90) reports that administration 
of 6-MP during the primary response has little effect on the secondary 
response, but X-irradiation or cyclophosphamide given during the 
primary response inhibits the secondary response. Another interesting 
effect of immunosuppression on the productive phase is that low doses 
of 6-MP extend IgM production while IgG synthesis is diminished (85).
Turning attention to drug effects on cellular immunity, inter­
pretation of immunosuppressive effects on delayed hypersensitivity 
depends upon whether suppression is occurring at the level of the 
immunological mechanism which is specific and has a distinct induction 
period or on the nonspecific level of the inflammatory reaction. For 
example, both MTX and cyclophosphamide block development of primary 
contact sensitivity in the guinea pig (99). However, following passive 
transfer of sensitized donor lymphoid cells to drug-treated hosts,
MTX-suppressed recipients elicit a good delayed hypersensitivity 
response while cyclophosphamide-suppressed recipients are unable to 
evoke a delayed reaction. Apparently cyclophosphamide affects 
both specific and nonspecific phases of cellular immunity and MTX 
inhibits only cellular proliferation. Some drugs such as 6-MP 
exert more suppression on delayed hypersensitivity than humoral 
immunity (15), a fact which indicates that delayed hypersensitivity 
involves a distinct population of cells rather than simply bio­
chemical changes in the same population of immunologically reactive
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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cells,
l-lany immunosuppressive agents are used to retard the cellular 
changes occurring during homograft rejection, hut use of cortisone 
during kidney transplants is one of the few treatments of clinical 
significance. Such variability between donor, recipient, and graft 
exists that Interpretation of experimental data becomes difficult, 
Scothorne (81) finds that cortisone treatment prevents immunoblast 
formation and development of granulation tissue in rabbits with skin 
grafts while thalidomide effectively suppresses graft rejection if 
given to both donor and recipient prior to grafting (102), These 
drugs probably suppress differentiation of the small lymphocyte, the 
cell responsible for mediating cellular and humoral immune responses.
The next consideration is the induction of immunologic tolerance 
by drugs. Tolerance is that process in which a host is unable to 
respond to a particular antigen but exhibits normal response to 
other antigens. Tolerance may further be subdivided into those 
processes in which antigen induces the lack of response and those 
in which the immune response is present but masked. Early work 
reports that adult mice infected with lymphocytic choriomengitis 
(LGM) resist infection if treatment with MTX in initiated (46), 
Schwartz and Dameshek (8^0 also show that tolerance to hunan serum 
albumin is induced by giving 6-MP with the antigen. Tolerance 
is specific because antibodies may be produced to bovine gamma 
globulin given one month later but not to a second dose of human 
serum albumin. Dose of antigen is extremely critical and not all 
antigens are tolerogenic. Concerning clinical application of drug
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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induced tolerance, elimination of antibody secreting cells by drug 
treatment may increase the population of tolerant cells. In this 
manner tolerance to a particular antigen may be maintained without 
continued administration of drug therapy.
Having briefly considered levels of the immune response which 
are subject to suppression, a review of some of the classes of immuno­
suppressive drugs will be covered. Immunosuppression may be divided 
into four general categories; cytotoxic chemical, corticosteroids, 
irradiation, and biologic agents. The category of cytotoxic 
chemicals encompasses alkylating agents, folic acid antagonists, 
antimetobolites of purine bases, analogs of pyrimidine bases, anti­
biotics, and plant alkaloids.
The cytotoxic agents act nonspecifically by altering basic 
metabolic functions in cell division, differentiation, and protein 
synthesis. Their therapeutic usefulness is limited by toxic side 
effects, especially the indiscriminate suppression of most stages 
of the immune response. It is interesting to note that depending 
on dose and timing, enhanceiû ivL rather than depression of the immune 
response results, Lance (51) offers possible explanations such as 
Lebensraum, increased availability of nucleic acids for replication, 
or perhaps feedback of some immune suppressor mechanism.
One of the earliest alkylating agents, nitrogen mustard, was 
developed for use in chemical warfare in World War II, This agent 
produces atrophy of lymphoid tissue and was introduced for treatment 
of leukemias and lymphomas. Alkylating agents, typified by nitrogen 
mustard, cyclophosphamide, and busulfan are thought to bind to
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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electron-rich nucleophilic centers of DMA (especially the N? 
of guanine) and protein in rapidly dividing cells such as the
small lymphocytes (83). These agents form cross links between 
DNA-DNA, ÜNA-RNA, ilHA-RNA, DMA-protein, and RNA-protein resulting 
in impaired protein synthesis and lymphopenia. Cyclophosphamide 
affects induction of primary and secondary antibody responses as 
well as ongoing antibody production if given on the same day as 
antigen or several days before (l). Macrophage ptogocytosis of 
carbon particles apparently is not inhibited by cyclophosphamide, 
but proliferation of macrophages and antigen retention in the spleen 
is decreased (63). Cyclophosphamide also has a profound inhibitory 
effect on development of delayed hypersensitivity if given prior to 
the antigen (lOl), Thus, the effect of alkylating agents is 
thought to occur early in the induction of the immune response, 
probably at the level of RNA synthesis. Alkylating agents, though 
extremely toxic, have been used clinically for treatment of 
leukemias, multiple myeloma, certain types of carcinomas, and 
neuroblastoma and experimentally to inhibit development of ex­
perimental allergic encephalomyelitis (iCAC) and allograft rejection.
The folic acid antagonists, such as aminopterin and amethopterin 
(methotrexate), have limited use in man due to their extreme toxicity, 
These agents block the conversion of folic acid to tetrahydrofolic 
acid by Inhibiting the action of the enzyme dihydrofolate reductase. 
The ultimate effect is inhibition of metabolism of one-carbon units 
and eventually synthesis of DMA, RNA, and proteins. Methotrexate 
also blocks differentiation of immunoblasts into small lymphocytes
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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by selectively depressing dehydrogenase activity (30), Interestingly, 
the effect of methotrexate may be reversed by administering large 
doses of folinic acid, thus reducing toxicity while maintaining 
immunosuppression. Folic acid antagonists cause remarkable 
suppression of primary and secondary antibody induction, (?3 antibody 
selectively), if given within 24 to 48 hours following antigen or 
within 72 hours prior (80,98), However, methotrexate is ineffective 
in suppressing ongoing antibody synthesis. Cell-mediated immune 
responses such as delayed hypersensitivity to tuberculin and 
contact sensitivity to oxazolone may also be abolished by folic 
acid antagonists if the drug were administered within four days 
following sensitization (lOl). Reconstitution of drug treated 
mice with cells of sensitized donors confers delayed type sensitivity. 
Other cell-mediated immune responses such as graft versus host 
reaction and allograft rejection are also suppressed by these 
agents. Folic acid antagonists probably inhibit DNA selectively 
since iiuaunoblasts develop normally, but development of specific 
populations of small lymphocytes is blocked even if given after 
onset of the disease (lOO), Methotrexate is used experimentally in 
suppressing LGM infection in mice and EAE in quinea pigs and rabbits. 
Clinically, methotrexate is accepted for treatment of severe 
psoriasis, some carcinomas and leukemias, and uveal disease.
The antimetabolites of purine bases, characterized by 6-MP,
6-TG, and azathioprine (Imuran), are synthetic substances which 
interfere with the biosynthesis of nucleic acids by competing with 
the nitrogen bases adenine and quanine. Suppression of the ?S
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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primary antibody response to the intracellular parasite Listeria 
monocytogenes is accomplished by administering antigen and azathioprine 
on the same day. However, 193 antibody is not suppressed and may 
even be enhanced (98). In contrast, azathioprine has no effect on 
passive transfer of cell-mediated immunity. Mice protected with 
immune lymphoid cells to Listeria monocytogenes did not succumb 
to infection when given the drug on the day of immunisation or 24 
hours prior to passive immunisation (97). Apparently, azathioprine 
is not effective against immunologically active cells but may be 
restricted to suppression of the inductive phase of immunity.
This drug is used extensively in both clinical and experimental 
suppression of allograft rejection of kidneys, hearts, and livers, 
especially in combination with other immunosuppressive regimens.
Recent use of azathioprine in treatment of systemic lupus 
erythematosus and glomerulonephritis reveals arrest of the diseases 
with subsequent suppression of the inflammatory response.
Analogs of pyrimidine bases are mainly used 3^ vitro to 
study the secondary antibody response. The chemicals ^-bromo- 
deo^yuridine (BUDR) and ^^fluoro-uracll deoxyriboside (FUDR) 
are important carcinostatic and virostatic agents which replace 
uracil and result in the synthesis of abnormal DMA, Cytosine 
arabinoside and 6-azauridine inhibit DNA polymerase and are incor­
porated into DMA and RNA, Experiments with FUDR treatment in 
cancer patients reveal inhibition of primary antibody response in 
80?o, suppression or delay of secondary response in about 40>î, and 
depression of delayed hypersensitivity to skin sensitizing antigens 
(60), Cytosine arabinoside affects macrophage differentiation.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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inhibits ?S antibody production, mainly in vitro, and markedly 
suppresses cell-mediated immune responses (4^).
Use of antibiotics as immunosuppressants is confined mostly to 
in vitro studies. To cite a few, the actinomycins bind to quanine 
residues of DMA and interrupt DHA directed RUA synthesis. 
Chloramphenicol inhibits bacterial protein synthesis by binding to 
mRHA and by suppressing the activity of peptidyl transferase (39). 
The antibiotics may interfere with the humoral response either by 
inhibition of antibody synthesis, by interaction with mRlïA or 
tRHA, or by alteration of the genetic code.
The plant alkaloids deserve mention because of their use in 
combination chemotherapeutic regimens. Such agents as vincristine 
and vinblastine, derivatives of the periwinkle plant, and 
colchicine, an extract of the autumn crocus, block spindle 
formation during metaphase of cell mitosis. In addition colchicine 
probably inhibits phagocyte digestion of foreign particles. The 
vinca allcaloids suppress antibody response and DH if given with 
or after antigenic stimulation (56) whereas colchicine is only 
effective in suppressing antibody response,
Niridazole (Ambilhar), a now anthelminthic drug introduced in 
1964, is used in the treatment of schistosomiasis. The agent is a 
nitrothiazole derivative 1-(5-nitro-2thiaaolyl)-2“imidazolidinone, 
The drug is apparently concentrated in adult worms and inhibits 
phosphorylase activation, resulting in decreased glycogen levels in 
the schistosomes (43). I%Lhmoud and Uarren (54) report remarkable 
suppression of cell-mediated immunity by niridazole resulting in 
reduced schistosome egg granuloma and delayed footpad swelling to
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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soluble egg antigens. In addition, niridazole is more effective in 
maintaining allograft survival to strong histoincompatibility antigens 
than other immunosuppressive agents currently used in organ trans­
plantation (55)• Furthermore, niridazole apparently lacks the 
toxic side effects of other immunosuppressants. Decrease in white 
blood cell counts, bone marrow, or increased susceptibility to 
infection are not noted (41,06). The mechanism of action of 
niridazole is not understood but may involve suppression of non­
specific inflaiOJTiatory reactions (72). Influence of this drug on 
Immoral immunity has not been extensively studied, but a recent 
report indicates tliat continued niridazole therapy depresses 
antibody production (6?).
It is noted earlier that immunosuppression may affect one or 
more phases of the immune response, from antigen processing, 
through cell differentiation and proliferation, and eventually 
antibody secretion and actions of sensitized cells. Glucocor- 
ticosteroid hormones are thought to liave the unique attribute of 
affecting each stage of the immune response. These are the most 
commonly used drugs for the suppression of undesirable immune or 
inflammatory responses, especially with regard to homotransplantation. 
Even though clinical application is extensive, considerably less is 
known about the cellular responses through which the effects occur, 
Uhen interpreting data with corticosteroids, species differences 
must be kept in mind. Mouse, rat, hamster, and rabbit appear to be 
steroid-sensitive while man, guinea pig, and monkey are relatively 
steroid-resistanb (23). The exact basis for these differences is 
unknown.
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One of the effects of corticoids is upon peripheral leuko­
cyte populations. Transient but selective decreases in circula­
ting lymphocytes and monocytes and an increase in neutrophils 
occur in man within four to six hours following corticosteroid 
therapy but these cells return to normal levels within 24 hours 
(36, 71). Circulating T lymphocytes decrease, probably as a result 
of redistribution to other areas of the body (26,34,35,108).
During the period of lymphocytopenia functionally mature lympho­
cyte subpopulations are detected in the bone marrow, even though 
total numbers of bone marrow lymphocytes remain constant. Therefore, 
the bone marrow assumes increased immunocompetence while the 
circulating lymphocyte population becomes immunosuppressed.
Corticosteroids also have an influence on the humoral immune 
response. Corticosteroids are used to control some of the symptoms 
associated with IgG and IgM humoral antibody responses in certain 
allergic and autoimmune diseases. It is reasonable to ask 
whether corticoids prevent induction and/or expression of the immune 
response and what cell types are affected. Administration of 
methylprednisolone to human volunteers results in decreased 
IgG and IgA but no significant decrease in IgM levels (17). It 
was shown by studies with ^^^I-IgG that corticosteroid-induced 
decreased IgG synthesis accounts for 90% of the decrease in serum 
IgG levels. Increased catabolism of IgG accounts for the 
remaining 10%. Cohen (25) repopulated lethally irradiated mice 
with bone marrow and either normal or hydrocortisone-treated 
thymus cells. Mice in both groups mounted equal antibody responses 
to SRBC’s, which is surprising since thymus glands of cortisone-
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treated mice contain only of the lymphocytes normally present.
This suggests that 5:̂  of the thymus lymphocytes which are corti­
costeroid-resistant are also immunocompetent. Antibody production 
by spleen cells, a function of T and B cells, is suppressed but 
may be restored by administration of bone marrow cells of normal 
mice. The B cell precursor thus appears to be the corticosteroid- 
sensitive step in induction of humoral immunity, Cohen finds 
mature antibody secreting cells to be corticosteroid-resistant.
In contrast, Butler (l?) reports that human volunteers on methyl­
prednisolone therapy develop high levels of circulating antibody 
to keyhole limpet hemocyanin, diphtheria toxoid, tetanus toxoid, 
adenovirus vaccine, and influensa-virus vaccine, even though 
total IgG serum concentration decreases. lie also notes that 
naturally acquired herpesvirus titers drop, indicating inhibition of 
ongoing antibody synthesis or expression of humoral immunity.
Corticosteroids may also alter cell-mediated inununity such 
as delayed hypersensitivity, contact sensitivity, allograft 
rejection, and graft versus host (CVIl) reaction. These pheno­
mena are regulated by T lymphocytes which contact specific antigen 
and are stimulated to divide and secrete soluble factors. The 
visible inflammatory lesion is a result of localization of i.on- 
specific cellular elements. Corticosteroids inhibit the Inflammatory 
response,but is it at the level of the lymphoid initiator cell 
or the ensuing nonspecific response? In order to discuss the 
differential sensitivity of T cells, it is necessary to consider 
each of the T Cell functions. It lias already been pointed out that
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all but 5/» of the thymus lymphocytes are corticosteroid-sensitive, 
but the remaining cells manifest inununocompetence in eliciting GVH 
and helper cell function in lethally irradiated hosts. Cohen (25) 
establishes that hydrocortisona inhibits the GVH reaction. He 
transfers parental strain lymphoid cells, control and hydrocortisone- 
treated, to F^-hybrid hosts and notes enlarged spleens in only 
animals receiving control lymphoid cells. Parental lymphocytes 
apparently home to the recipient's spleen and are stimulated to 
divide by histoincompatibility antigens. These stimulated donor 
cells release factors which result in proliferation of the recip­
ient's cells and also in a nonspecific inflammatory response to 
injury. Spleen and thymus cells of hydrocortisone-treated parental 
donors, however, do not protect Fj-hybrids from the GVH reaction. 
Therefore, he postulates that hydrocortisone suppresses the non­
specific inflammatory response and not the T cells initiating 
the GVH reaction. In contrast to the steroid resistance of T 
cells activated by antigen, T cells activated by the nonspecific 
mitogen phytohemagglutinin (PHA) are corticosteroid-sensitive 
(13,19,36). After activation by antigen or mitogen, T lymphocytes 
affect other cells via direct cell contact or through the production 
of soluble mediators. Little is known about the vivo effects of 
corticosteroids on lymphocyte-produced mediators of cellular immunity. 
According to Williams and Granger (IO5) corticoids inhibit PIIA- 
induced lymphotoxin production by human lymphocytes. Furthermore, 
macrophage migration intiibitory factor (MIF) is released by 
lymphocytes of corticosteroid-treated guinea pigs, but macrophages 
of these animals are unable to respond to MIF. Thus, steroid hormones
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appear to interfere with the effector limh of lymphocyte mediator 
function. In summary, figure 1 shows the differential sensitivity 
of lymphoid subpopulations to corticoids.
Considerable work has been done to elucidate the mechanism of 
glucocorticoid action. Recent work suggests tliat physiological 
responses to steroid hormones are mediated through specific 
intracellular protein receptors (lO), Steroids penetrate the 
membrane and bind to the receptors inside the cell. Loss of 
receptor correlates with loss of steroid sensitivity. Steroid binds 
with the receptor, which probably undergoes a conformational 
change allowing close association of the recepkor-steroid complex 
with DIIA, Accumulation of mRNA then occurs, but the mechanism does 
not explain the exertion of an inJriibitory effect by glucocorticoids 
during increased RNA synthesis.
Whole body irradiation by X-irradiation is one of the 
earliest forms of immunosuppression. Inhibition of antibody 
response and suppression of graft rejection can be accomplished by 
administration of X-ray prior to injection with antigen. The 
treatment destroys lymphocytes and stem cells but also damages 
severely other hematopoietic and tissue cells. Local application 
of irradiation to tumors or grafted skin or organs reduces the 
toxicity problem but also limits the contribution of X-irradiation 
as an immunosuppressant (51).
A variety of biological agents and surgical treatments are 
also available for suppression of the iffonunc response. Anti­
lymphocyte serum is a potent inhibitor of cellular immunity and
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Figure 1. Fluctuation of sensitivity and resistance of lymphoid 
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does not produce the toxic side effects of other immunosuppressive 
agents (75). Antilymphocyte serum binds to the recirculating 
population of antigen-reactive cells, which are then eliminated by 
cytotoxic destruction. Humoral inunune responses to T-cell-dependent 
antigens may also be decreased by antilymphocyte serum. Specific 
elimination of cellular immunity by this antiserum increases the 
possibility of lowered host resistance and generation of spontaneous 
neoplasms. Viral infections with non-oncogenlc (68) and oncogenic 
(74) viruses may cause immunosuppression of either compartment of 
the immune response. Surgical removal of thymus, spleen, or lymph 
nodes may result in depletion of specific populations of cells.
The opportunities for Immunosuppression, table 2, range from 
specific to nonspecific, physical, chemical, and biological agents. 
Variations in dosage, schedule, and route of administration may 
result in suppression of virtually every phase of cellular and/ 
or humoral immunity. However, the immune responses most affected 
by the nonspecific immunosuppressive agents are listed in table 3.
Statement Of The Problem
Pour drugs are used in this study; hydrocortisone acetate, 
aaathioprine (Imuran), niridasole (Ambilhar), and amethopterin 
(Methotrexate). These drugs are classified as corticosteroid, 
purine antimetabolite, cytotoxic chemical, and folic acid antago­
nist respectively. Immunosuppressive drugs are used extensively 
although their effects on the imiaune system are poorly understood. 
For this reason, this study was designed to investigate the 
temporal response of a variety of immunosuppressive drugs on the
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Table 2, Immunosuppressive agents (nonspecific),
Physical af̂ ents 
Chemical agents
Biological agents
Living organisms
Removal of lymphoid 
tissue
Irradiation
Alkylating agents 
Purine analogs 
Pyrimidine analogs 
Folic acid antagonists 
Antibiotics 
Plant alkaloids 
Carcinogens
Enzymes
Hormones
Antilymphocyte serum 
Antimacrophage serum
Viruses
Parasites
Thymectomy 
Splenectomy 
Bursectomy in birds
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Table 3» Compartments of the Immune response most affected 
by various immunosuppressive agents.
Ap;ent Compartment
a ) Cytotoxic chemicals
alkylating agents 
antimetaboli tes 
folic acid antagonists 
antibiotics 
plant alkaloids
B) Corticosteroids
C) Irradiation
D) Biologic agents
thymectomy
antilymphocyte serum
ensymes
bursectomy
humoral
Cell-mediated
Humoral
Cell-mediated
Cell-mediated
Cell-mediated
Humoral
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T and B lymphocyte compartments of the immune response using 
the mouse system as a model. Understanding mechanisms of 
action may px-ovidc a rational basis for immunosuppressive therapy,
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Chapter 2 
i-LfVTCRIALS and MlîTliODS
Animal;
Male Cwlss-’iebster mice were obtained from a colony main­
tained by Rocky Mountain Laboratory, Hamilton, Montana. Mice 
used for all investigations were five to six weeks of age.
Drugs
Hydrocortisone acetate (Microfine), Towne, Paulsen, and Co.,
Inc. Monrovia, California 91016, was suspended in cortisone diluent 
(Table 4) to concentrations of 10 mg/ml, 20 mg/ml, or 40 mg/ml.
Mice wore injected subcutaneously in the nuchal area with I50 mg/kg, 
350 mg/kg, or 600 rag/kg body weight.
Imuran^ brand azathioprine, Burroughs Wellcome Co., Research 
Triangle Park, Morth Carolina 27709, ifas dissolved in O.83/ 
sterile saline to a concentration of 10 mg/ml. Mice were injected 
subcutaneously in the nuchal area with I50 mg/kg body weight,
I.'lx'idaaolc, Ciba Ptiarmaceutical Co., Division Ciba-Geigy
I
Corp. , Gummlt, Hew Jersey 07901, ifas suspended in sterile 
distilled water to concentrations of 2 mg/ml and 20 mg/ml. The 
drug was administered orally by using a 1 ml syringe with attached 
beveled and bent (45^ angle) I6 gauge needle which could be inserted 
deep into the animals throat.
Methotrexate, Lederle Labs, Division, American Cyanamid Co., 
Pearl River, Hew York 10905» was dissolved in 0.5 M sterile Ka2Cû^ 
to a concentration of 40 mg/ml. Mice were injected intraperitoncally
23
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with 250 mg/kg body weight.
All di'ugs were administered 10, 0, 6, 4, 2 or 1 day prior 
to antigen or on the day antigen was administered.
Humoral Immune Response by Hemagglutination
Rabbit blood was obtained from an adult New Zealand white 
rabbit by cardiac puncture. Equal volumes of Alsevers solution 
(Table 5) and blood were mixed and allowed to equilibrate for 40 
hours. Cells were washed three times with 0.8^^ saline and 
centrifuged at I5OO rpm on a Universal centrifuge Model V for 
five minutes each time. Red blood cells were resuspended in 
0.B5:’5 saline to a concentration of 2.5'/’̂. Mice were immunized 
intravenously via the tail vein with 0,2 ml of the rabbit
red blood cell suspension using five mice/group. Mice were bled 
from the axillary artery five days later, and serum vfas collected. 
All sera were heat inactivated at ^6°C for 30 minutes. Hemagglu­
tination was performed on serial two-fold dilutions of serum by 
the microtiter method with the materials of Cooke Engineering Co., 
Alexandria, Virginia. Rabbit red blood cells were washed three 
times with 0.35/J saline and resuspendcd to a concentration of 2,a 
in 1% normal rabbit serum, which was prepared in saline. Diluent 
was 1/0 normal rabbit serum in saline. The reaction was incubated 
at 37^0 for one hour then overnight at room temperature.
Delayed Hypersensltivity (üil) Response by Oxazolone Sensitization 
According to the method of Asherson and Ptak (2), seven mice/ 
group ifere sensitized prior to or following drug administration by 
applying 3:̂  oxazolone (4-Ethoxyinethylene-2-phenyl oxazolone) 3OH 
laboratory Reagents, BDH Chemicals Ltd., Poole, England, in
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absolute ethanol to the preshaved abdomen using 0,1 ml/mouse.
The solution was rubbed in with the lengthwise edge of a 20 guage 
needle. Seven days following the final day of drug treatment or 
oxazolone sensitization, 2,j oxazolone in absolute ethanol: olive 
oil (l;l) was applied to both ears of sensitized mice, 1 drop/ear 
delivered from a 25 gauge needle. The emulsion was rubbed in 
extensively with a cotton tipped applicator stick. Skin tests 
were read at 24 hours by measuring double ear thickness with a 
Schnelltaster, Results were reported as group averages and percent 
of control ear thickness,
1‘Viend Disease Virus Infection of Drug Treated Animals
Friend Disease Virus (PDV) was obtained from the Stella 
Duncan Research Institute, University of Montana, Missoula,
Montana, The institute prepared stock pools of the virus after 
three passages were made in 3wiss-iiebster mice at The Rocky 
Mountain Laboratory, Hamilton, Montana,
To prepare working stock suspension, 30 male mice were in­
jected with 0.2 ml of 10 dilution of FDV, After 28 days the 
mice were sacrificed and the spleens were removed and suspended 
in cold medium, consisting of chemically defined Medium 199 (m-199), 
GIBCO, Grand Island, Hew York, and diluted to a concentration of 
20'̂ . After teasing the tissues over a wire mesh and placing into 
two 40 ml plastic centrifuge tubes, the suspension was centrifuged 
at iCOO rpm in an RC-2 Sorvall refrigerated centrifuge for 15 
minutes at 4®C, The supernatant was then collected and centrifuged 
at 6000 rpm for 30 minutes at 4°G, The top 2/3 to J>/h of the clear
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supernate was removed and pooled. Aliguots of 0.6 ml were 
distributed in 2 ml ampoules, sealed, and frozen in a Revco 
freezer at -70^C.
Following drug treatment, mice were injected intravenously 
with 0.2 ml of a 10 dilution of FDV using 10 mice/group (96).
On day 14 all animals were weighed and autopsied. Spleens were 
removed, weighed, and fixed in Bouin's fixative (Table 6). Viral 
plaques were counted after 18 hours fixation, according to Axelrad 
and Steeves (3).
Blood Cell Counts and Differentials
Blood was collected from the axillary artery of drug treated 
mice. Whole blood was diluted 1:500 with 0.85% saline for red blood 
counts and 1:20 with Turk's diluting fluid (Table 7) for leukocyte 
counts. Counting was accomplished using a Neubauer hemocytometer. 
Differential leukocyte counts were performed on blood smears 
stained with Giemsa (Table 9).
Immunofluorescence
Drug-treated mice were sacrificed and their spleens immediately 
placed in cold m-199 plus 10% Fetal Calf Serum and 10% triple dis­
tilled water containing five units preservative free heparin/ml. 
Spleens were teased through a wire mesh into 10 ml cold media.
The cell pellet was resuspended in 10 ml cold media and layered over
10 ml of Ficoll-Hypaque (Table 8) in 40 ml Sorvall centrifuge tubes.
oCentrifugation was carried out at 1500 rpm for 20 minutes at 4 C 
in an International portable refrigerated centrifuge model PR-2.
The white lymphocyte layer was removed and washed three times in
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cold, media. Lymphocytes were counted using a Neubauer hemocyto- 
meter and were resuspended in media to a concentration of ^ X 10 
cells/ml. Cells (O.l ml) were placed in Corning centrifuge tubes 
(2 mm X 30 mm) and 0.1 ml of a 1:4 dilution of mouse anti-serum 
globulin (rabbit origin) conjugated with fluorescein isothiocyanate 
(Pirc), Colorado Serum Co., 4950 York Street, Denver, Colorado, 
was added. All tubes were incubated for 45 minutes at 4°C. Following 
incubation cells were centrifuged at 1200 rpm for one minute and 
washed three times with 0,4 ml cold media. Lymphocytes were 
resuspended in two drops of media and placed on a glass slide with 
cover slip. Paraffin was used to seal the edges of the cover slip.
All slides were viewed using a Zeiss fluorescence microscope with 
excitation filters 1 and III and barrier filters 50 and 0, A 
total of 200 cells/slide were counted, fluorescent cells being 
scored as B cells and non-fluorescent cells as T cells. Cells 
showing diffuse fluorescence rather than strictly membrane 
fluorescence were considered nonviable and were not counted.
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Table 4. Cortisone diluent.
Saline 0.85^
Tween 80
Benzyl Alcohol
Carboxy methyl cellulose
Add in order given.
98.7 ml
0,4 ml Nutritional Biochemical Corp.
0,9 ml J.T. Baker Chemical Co.
0.5 g Svenka Cellulosa AB 
Sundsvall, Sweden
Table 5# Alsevers solution. 
Dextrose
Sodium citrate (dihydrate) 
Citric acid (monohydrate) 
Distilled water
20.5 g
8.0 g
0.55 g 
to 1 liter
Dissolve ingredients successively in distilled water. Autoclave 
at 15 psi for 15 minutes. pH should be 6.1. Use 1 part bloodt 
1 part Alsevers.
Table 6. Bouin's fixative.
Picric acid (saturated aqueous, filtered) 73 ml
Neutral formalin (filtered) 25 ml
20 g sodium acetate plus 100 ml 40g( formalin
Glacial acetic acid 5 ml
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Table 7. Turk's white blood cell diluting fluid,
Glacial acetic acid 2 ml
Aqueous gentian violet IfC w/v 1 ml
Distilled water 100 ml
Mix and filter.
Table 8, Picoll - Hypaque.
1. Dissolve 9.34 g sodium diatrizoate, Winthrop Laboratories,
90 Park Ave., New York, New York 10016, in 30 ml distilled 
water and adjust to pH 7.3.
2. Add 72 ml distilled water.
3. Dissolve 6.28 g Ficoll, Pharmacia Pine Chemicals AB,
Uppsala, Sweden, in above solution.
4. Encase bottle in foil and autoclave for 15 minutes at 121*0.
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Table 9. Giemsa stain for mouse blood cells.
Stock giemsa: 1. Dissolve 0.5 g giemsa powder in 33 ml glycerine.
2. Heat at 55 - 60°C for Ih to 2 hours.
3. Add 33 ml absolute methanol.
0.15 M phosphate buffered saline pH 6.4: (PBS)
0.85% saline 100 ml
0.15 M Na^HPO- 32.2 ml—  2 4
0.15 M KHgPO^ 67.8 ml
1. Fix smears in absolute methanol for 10 seconds or longer.
2. Allow slides to air dry.
3. Rinse a small test tube with 5 ml distilled water and add 
another 5 ml distilled water to the tube. Add a few crystals
of hematoxylin to the test tube. If the water appears yellow the 
pH must be adjusted. Add about 0.1 ml 1% KCO^/ 200 ml 
distilled water. The color of the water in tne 5 ml tube 
should be light pink in color when hematoxylin is added.
4. Use 0.2 ml stock giemsa/ml PBS pH 6.4. Flood smear with 
3 ml/slide for 30 seconds.
5. Float off stain with adjusted distilled water.
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Chapter 3 
RESULTS
Hydrocortisone Acetate
The initial experiments were designed to investigate the 
temporal effects of cortisone on humoral and cell-mediated im­
munity. In general cortisone markedly diminished both components 
of the immune response for four days following drug administration. 
Administration of antigen shortly after administration of drug 
resulted in a decrease of circulating antibodies to rabbit red 
blood cells (Figure 2). Increase in time intervals between drug 
txreatment and antigen administration effected a recovery of the 
antibody response which was apparent by day 10. There were no 
significant variations in the antibody titer of groups of mice 
receiving different doses of hydrocortisone acetate. Since red 
blood cells are T-lymphocyte-dependent antigens, it was not 
possible to determine idiether suppression occurred at the level 
of the T-cell precursor, B-cell presursor, or both. Therefore, 
the experiment was repeated using the T-cell-independent antigen 
lipopolysaccharide. With this antigen, a decreased antibody 
titer was noted only one or two days following cortisone treatment.
The ability of mice sensitized to oxazolone and treated with 
cortisone to express a delayed reaction was studied. This ability 
to express a OH response was essentially abolished during the first 
four days following cortisone treatment but gradually increased to
31
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control levels by day 10 (Figure 3). While the pattern of 
reaction was similar in mice given different doses of cortisone, 
recovery was much less in those given larger doses of drug.
However, if mice were given cortisone and then sensitized with 
oxazolone in order to determine the action of drug on the 
afferent arm, the initial lack of DH at day zero was followed 
by gradual increase in skin sensitivity culminating in marked 
enhancement of the DH at day 4, after which the response declined 
and approached control levels (Figure 4). Skin tests were repeated 
on the oxazolone pre-sensltlzed mice between ten and twenty days 
following cortisone treatment and from 30 to 60^ recovery of the 
DH response was noted. The nonspecific inflammatory response was 
eliminated as shown by the absence of inflammation in ears of 
skin-tested hydrocortisone-treated mice. Both the affeetor and 
effector arms of the DH reaction were disturbed in mice treated with 
cortisone but to different degrees at various times after admin­
istration of the drug.
The weight of the spleens of drug-treated mice showed a 
remarkable decrease through day 4 and was followed by a gradual 
Increase which was less apparent in mice given the larger doses 
of cortisone (Figure 5)» The wei^t of spleens of control mice, 
however, always increased in size with age.
Interestingly, cortisone-treated mice (l50 mg/kg) were as 
susceptible to FDV infection as control mice (Figure 6). Other 
investigators (21,?6) have noted that mice with suppressed humoral 
immunity do not exhibit increased spleen weights or spleen viral
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foci (plaques) idiich are quantitative measurements used to detect 
PDV Infection. This may suggest that hydrocortisone Immunosuppression 
Is directed against the T-lymphocyte precursor rather than the 
B-lymphocyte precursor. Data from the 350 mg/kg cortisone-treated 
mice appeared confusing. Viral foci were nearly confluent In 
spleens of all Infected mice, but spleen weights fluctuated con­
siderably. Spleen sizes of Infected mice Increased over control 
spleens If FDV was given one or two days following cortisone 
treatment, decreased rapidly when FDV was administered four days 
following drug treatment, and gradually Increased at time Intervals 
thereafter. Generally, spleen size and plaque number correlate 
well, whereas In this experiment spleen weight was low even trtille 
spleen plaque numbers were high.
Spleen B cell populations were assayed by Immunofluorescence.
Data was difficult to obtain during the first days Immediately 
following drug administration because of the drastic reduction In 
spleen size. However, on the basis of other sampling Intervals 
total spleen B cell populations appeared only minimally depressed 
throughout the course of treatment (Figure 7).
In order to determine the effect of different doses of 
cortisone on populations of perl|dieral white blood cells, total 
white and red blood cell counts and differentials were performed. 
Variations for total red blood cell counts were within normal ranges 
In all cases. Total white blood cell counts of mice treated with 
150 mg/kg cortisone fluctuated around the lower range of counts 
for untreated controls. Mice treated with 350 mg/kg cortisone 
had counts lower than normal for the first two days, peaked
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sharply on day 6, and then gradually declined. Leukocyte 
responses of mice treated with high doses of cortisone (600 mg/kg) 
closely resembled those of mice treated with the intermediate dose. 
Relative to the total white blood cell count, neutro^il numbers 
were elevated throu^ the fourth or sixth day in all cortisone- 
treated groups and then started a gradual decline (Figure 8). 
Lym]^ocyte numbers dropped through day 6 and then began a gradual 
recovery. Monocyte levels remained depressed throughout cortisone 
treatment. These selective alterations in leukocyte populations 
agree with data obtained from humans on corticosteroid therapy (36),
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Figure 2. Effect of hydrocortisone acetate (administered on day 
zero) on the humoral immune response of mice to rabbit 
red blood cells. Each point represents pooled sera of 
five mice. HA = hemagglutination titer.
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Figure 3. Effect of hydrocortisone acetate (administered on day 
zero) on the DH response of mice previously sensitized 
with oxazolone. Each point represents pooled measurements 
from both ears of seven mice.
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Figure 7. Effect of hydrocortisone acetate (150 mg/kg administered 
on day zero) on B cell populations in spleens of mice 
as assayed by fluorescent antibody.
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on day zero) on populations of circulating leukocytes.
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Aaathioprine
Based on experiments conducted in this study, immuno­
suppression by azathioprine was not particularly impressive.
Humoral antibody responses as measured by hemagglutination of 
rabbit red blood cells were depressed by only one 2-fold dilution 
when drug was given either on the day of rabbit red blood cells or 
one day prior to antigen (Figure 9). A sharp peak occurred when 
drug was given eight days prior to antigen. These results were in 
agreement with those of Tripathy (98) who found that production of 
19S antibody to Listeria monocytogenes was not suppressed and, in 
fact, appeared to be enhanced.
There was a heightened DH response to oxazolone on the eighth 
day following drug treatment in mice previously sensitized with 
this agent (Figure 10). The other deviation observed was de­
pression of the DH response between four and six days following 
administration of the drug. Since azathioprine interferes 
primarily with induction of immunity, lymphocytes sensitized to 
oxazolone prior to drug treatment were present and functional 
several days following challenge with azathioprine. Depression of 
DH at day 4 may indicate that azathioprine eliminates some of 
these oxazolone-sensitized lymphocytes. Apparently compensation 
by production of more sensitized cells is manifested by day 8 
following drug treatment.
Susceptibility of azathioprine-suppressed mice to PDV was 
decreased when FDV was given within two days following drug treat­
ment but compared closely with control animals thereafter (Figure ll)
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Apparently B cells are Important for viral replication and 
intervals of suppression of humoral immunity correlated with 
decreased spleen wei^t and plaque numbers during FDV infection.
Spleen weights of drug-treated mice revealed no variation from 
control spleen weights except for a sharp peak in wei^t at day 6 
(Figure 12). Hiis rise may correlate with B cell increase 
during peak antibody titer and depressed DH at this time.
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Figure 9. Effect of azathioprine (150 mg/kg administered on day 
zero) on the humoral immune response of mice to rabbit 
red blood cells. Each point represents pooled sera of 
five mice. HA = hemagglutination titer.
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Figure 12. Effect of azathioprine (150 mg/kg administered on day 
zero) on spleen weights of mice.
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Nlrldazole
The Immunosuppressive potential of niridazole, which is 
relatively nontoxic, was investigated because of repoirts citing 
marked suppression of DH to soluble schistosome egg antigens (54)* 
Antibody titer to rabbit red blood cells was decreased by only 
one 2-fold dilution throu^out the interval of drug treatment, 
which can hardly be considered a suppression of the humoral 
immune response (Figure 13). Recently humoral immune suppression 
by niridazole was accomplished by eight days of continued drug 
therapy (67). One dose of d m g  produced no noticeable suppression.
The DH response of mice previously sensitized with oxazolone 
was depressed only slightly between the fourth and sixth days 
following administration of the drug (Figure 14). However, on 
the eighth day remarkable etüiancement of the delayed response 
occurred with both high and low doues of drug.
Susceptibility of mice to FDV was not altered by niridazole 
treatment (Figure 15)* a result supported by the fact that 
humoral immunity was not depressed. Similar to azathioprine- 
treated mice, spleen weights of niridazole-treated mice peaked 
during the time of depressed IHl (Figure l6).
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Methotrexate
The folic acid antagonist methotrexate exhibits considerable 
toxicity and causes suppression of the humoral immune component 
of the Immune system. Hemagglutination titers to rabbit red blood 
cells were depressed during the entire ten day interval following 
drug treatment (Figure 1?). In close agreement, susceptibility to 
FDV was nearly abolished when methotrexate and FDV were given on 
the same day (Figure 18). Thereafter, susceptibility to infection 
Increased to levels comparable to controls suggesting that B 
lymphocyte recovery occurred well before recovery of antibody 
production. A decrease in the population of B lymphocytes in the 
spleen as assayed by immunofluorescence (Figure 19) correlated with 
the depressed antibody titer. Spleen wei^ts of drug-treated 
mice did not vary significantly from controls (Figure 20). 
Satisfactory data on the effect of methotrexate on the delayed re­
sponse to oxazolone was not obtained.
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of five mice. HA = hemagglutination titer.
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Chapter 4 
DISCUSSION
Studies of immunodeficiency diseases, the effects of surgical 
removal of lym^diold tissues, and Immunosuppression by drugs have 
aided In separating the two lymphoid cell populations Involved In 
the Immune response. The B lymphocytes are the antibody-producing 
cells of the humoral Immune system, and the T lymphocytes function 
as helper cells for antibody production to certain antigens and 
as mediators In cellular Immune responses. The T and B cells of 
animals treated with Immunosuppressive drugs during Induction of 
the Immune response differ In their sensitivity to various drugs. 
Therefoire, such drugs may affect natural resistance as Is evidenced 
by decreased resistance to Infections and tumors In Immunosuppressed 
hosts.
In this study the temporal effects of four drugs on the 
humoral and/or DH response are Investigated. The major emÿkasls 
Is placed on determining the effects of hydrocortisone acetate. 
Minimal studies with azathioprine, niridazole, and methotrexate 
are Included as a general reference to determine whether all of 
these Immunosuppressive drugs alter the Immune system In a similar 
manner.
Expression of DH
The effect of cortisone on the afferent and efferent arms
58
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of the delayed response to oxazolone differs with respect to the 
response at various intervals after administration of the drug. 
Following the administration of cortisone, expression (efferent 
arm) of the already established delayed reaction to oxazolone 
is almost wholly depressed for a period of four days. After an 
additional two days, the capability of mice to respond to a 
sensitizing dose partially returns, but complete recovery is not 
noted until the tenth day. These results suggest several possible 
effects of cortisone on committed T cells and/or perhaps only on 
innocent-bystander lymphocytes which are necessary for committed 
T cells to effect a lesion at the skin test site. One possibility 
mi^t be that the T cells are directly affected by cortisone and 
are unable to respond to an eliciting dose of antigen. Another 
is that some mechanism acts to prohibit migration of the committed 
cells from the immune cell "reservoir". Lastly, the T-cells 
may be distributed to other body compartments and become un­
available for expression of 1*1.
The effect of azathioprine and niridazole upon the efferent 
arm of the DH reaction does not follow the course observed with 
cortisone. There is a slight increase in the response on the day 
following administration of either of these drugs, and on day four 
and six the response is suppressed. In contrast to the gradual 
recovery noted in cortisone-treated mice, the response returns to 
normal or above normal levels in two days.
The mechanism of depression of T cell activity produced by 
treatment with azathioprine or niridazole may be qualitatively
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different than that produced by administration of cortisone. It Is 
essential, however, to point out that cortisone Is administered In 
a carrier which serves to cause a slow releaise of cortisone from 
a depot resulting In a prolonged clearance of the drug from the 
animal. If mice are Injected with cortisone alone, the length of the 
depressed state may be as short as that caused by azathioprine and 
niridazole. Furthermore, In the form administered, azathioprine 
and niridazole may be Inactive chemically. The means whereby 
these drugs exert their effect may differ since cortisone may exert 
Its effect directly on lymphocytes while azathioprine and niridazole 
require chemical alteration In order to exert their depressive 
properties. The recovery of the M  response would, therefore, 
occur more abruptly since altered chemicals may be rapidly 
eliminate!from the animal. Additional studies on the status of 
circulating lym^Aiocytes following administration of azathioprine 
and niridazole hopefully will provide Insight Into the similarities 
or differences between these drugs and cortisone.
Induction of DH
In the Induction (afferent arm) studies, separate groups of 
mice are treated with cortisone at various Intervals during a 
ten-day period and sensitized with oxazolone on the final day of 
drug administration. After an additional seven days the contact 
sensitivity assay is performed. In animals given cortisone two 
days before or at the time of exposure to oxazolone, the DH response 
Is depressed. However, unlike the effects of cortisone on the ex­
pression of the DH response, mice treated with cortisone, sensitized
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with oxazolone four or six days later, and skin tested after an 
additional seven days, respond with increased DH reactivity compared 
to untreated control animals. As mentioned previously, this pxx>- 
longed state of depression may be attributed to the "depot" effect.
It is of interest to observe that in the tests performed to determine 
the influence of cortisone upon either the afferent or efferent 
arm of the DH reaction to oxazolone, the animals recover their 
ability to respond normally about ten days after receiving cortisone. 
Taken at face value this observation indicates that T cells recover 
their ability to become sensitized and to produce lymphokines at the 
same time. There must, however, be a fundamental difference in the 
recovery of competent and committed T cells since it requires a 
period of about four days before competent cells are sufficiently 
activated to produce a state of delayed hypersensitivity (2).
Induction of Humoral Immunity
The effect of hydrocortisone acetate on the afferent arm of 
the humoral immune response indicates that T and B cells are dif­
ferentially depressed by the drug. Although the antibody response 
of mice to rabbit red blood cells (a T-cell-dependent antigen) is 
depressed during the entire interval of study, the response to IÆS 
(a T-cell-independent antigen) is depressed only on the first or 
second day following administration of cortisone. During these 
two days the spleen size is markedly reduced, and in most animals, 
lympAiocytes can not be obtained even from pooled spleen samples.
On the following days, however, the spleens begin to "regenerate", 
and B cells, assayed by immunofluorescence, are detected in sus-
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pensions of spleen cells. The depression of the antibody response 
to LPS is undoubtedly due to temporary functional absence of 
spleen lymphocytes and circulating B cells. B cells may be 
driven into another body compartment, such as the bone marrow (35)» 
but obviously are not present in the spleen. On the other hand,
B cells are available even though nonfunctional since it is observed 
that drug-treated mice are as susceptible to infection with FDV as 
are untreated controls. However, the T lym^^iocytes appear to be 
affected in a different manner. Depression of the antibody 
response to red blood cells suggests that T cells may be sequestered 
elsewhere in the body and are not available for contact with antigen 
or that cortisone alters antigen-recognition thus preventing 
stimulation of B cells for antibody production.
The mechanism of action of azathioprine and methotrexate 
differs from that of cortisone and from each other. The antibody 
response to rabbit red blood cells is depressed following treatment 
with either drug. However, azathioprine depresses the antibody 
response only tdien the drug is administered on the same day or one 
or two days prior to injection of antigen, Wiereas methotrexate 
depresses the humoral response throughout the entire period of 
study. On the other hand, susceptibility to infection with FDV 
decreases during the first two days following administration of 
either drug but is more persistent with methotrexate. These results 
indicate that B lymphocytes are either unable to respond to antigen 
or are unavailable for contact with antigen. The similarity in 
response of mice given azathioprine and methotrexate to infection 
with FDV and the difference in humoral antibody suppression in-
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dlcates that azathioprine is catabolized more rapidly. The B cells 
are susceptible to FDV by eighteen days following drug treatment 
but respond to antigenic stimulation four days after azathioprine 
treatment and some time past ten days following methotrexate.
Niridazole, however, apparently acts by an entirely different 
mechanism than that of the other drugs since no depression of 
antibody response or FDV susceptibility is observed.
Since macrophage function was not investigated in this study, 
further experiments might indicate whether the depression of DH 
and humoral immunity could also be attributed to the inability of 
macrophages to process antigen or respond to MIP,
Cortisone
The function of immunosuppressive drugs upon the two types of 
lymphocytes is variable, and the temporal effects on either B cells, 
T cells, or both will be reflected in the immunological response 
of the host. As shown by other investigators (23» 26 , 40), the 
action of glucocorticosteroids on the cellular and humoral immune 
responses is dependent upon the effect on the two populations of 
lymphoid cells. Corticosteroids are also used to suppress non­
specific inflammatory reactions, and are of value in controlling 
allograft rejection. The DH response is a combination of afferent 
and efferent processes. Macrophages process antigen and, in turn, 
stimulate T lymphocytes. These sensitized lymphocytes subsequently 
release chemotactic factors that, in addition to other functions, 
inhibit macrophage migration.
Corticosteroids suppress DH although the mechanism of action
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is unclear. According to Claman (23) and de Sousa and Fkchet (29) 
lymphocytes in the cortex of the thymus are steroid-sensitive. 
However, these cells become resistant during migration through the 
thymus medulla and maintain this resistance during uncommitted and 
committed stages of differentiation. In the mouse system a h i ^  
incidence of lysis of the thymus cortical lymphocytes is observed 
as early as four hours following cortisone acetate administration 
(l4, 29). By 24 hours cytolysis is complete and all nuclear debris 
is removed from the cortex. In contrast, human and guinea pig 
thymus cells are relatively resistant to ^  vitro lysis by 
hydrocortisone (24), indicating the species variability to drug 
suppression. Of interest is the observation that the cells subject 
to lymphocytolysis eure not immunocompetent since thymus cells from 
cortisone treated mice are more active in initiating GVH reactions 
than azre thymus cells from untreated animals (25)*
Using BHA-induced lymphocyte transformation as a measure of 
cell-mediated immunity, Webel et al (103) report maximal suppression 
of blastogenesis of peripheral lymphocytes within four hours 
following a single dose of methylprednisolone to human volunteers. 
Gradual return to normal lymphocyte transformation is apparent by 
72 hours. On the other hand, pokeweed mitogen stimulation of 
lymphocytes from steroid-treated subjects is not significantly 
impaired, suggesting a differential suppression of T and B cells.
As shown by Casey and McCall (20) using the macrophage 
migration test, the afferent arm of the DH response is inhibited when 
rabbits are treated with steroid at the time of sensitization with
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BCG. If steroid treatment is delayed until BCG sensitization has 
developed, inhibition of macroiAiage migration occurs. Furthermore, 
when BCG-sensitized lymphocytes are added to cultures of cells ob­
tained from steroid-treated rabbits the inhibition of macrophage 
migration is reestablished. Other researchers (?, 104) conclude 
that steroids do not block antigen processing by macrophages or 
synthesis of MIP by sensitized lymphocytes. Balow and Rosenthal (?) 
suggest that corticoids interfere with the macrophage response to 
MIF, perhaps via some alteration of the macrophage itself. Such 
an alteration mi^t be stabilization of the macrophage cell 
membrane which could prevent secretion of the macrophage lysosomal 
enzymes (82)•
Further data (73, 95) also indicates that macrophage-monocyte 
defects may contribute to the steroid-mediated suppression of 
cellular immunity which is apparent in patients receiving cor­
ticosteroids and manifested as increased susceptibility to 
infectious agents. Monocytes are those circulating cells which re­
spond to chemotactic stimuli, such as lymphokines or products of 
infectious agents, and mature into macrophages at sites of infection 
or inflammation. Corticosteroids may in fact interfere with inter­
action of monocytes and chemotactic stimuli thus inhibiting some 
trigger of crucial metabolic events.
In a recent series of papers (91, 92, 93) Stevenson refers to 
a polymorph migration stimulator factor (PMS) which is released 
from steroid-treated macrophages. Apparently monocytes interact 
with steroid jjj vivo and liberate PMS in vitro resulting in 
polymorph migration. The migration is dependent upon the presence
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of monocytes but not lymphocytes in the test chamber. Serum from 
steroid-treated patients does not stimulate polymorph migration 
until the euglobulin fraction is removed. A release of polymorphs 
from the bone marrow may be induced by PMS resulting in the increase 
of these cells in the circulation following corticosteroid treat­
ment. Since steroids prevent aggregation of polymorphs at in­
flammatory lesions (29), Stevenson suggests that PMS may induce 
functional changes in polymorphs which prevent their response to 
lymphokines or chemotaxins. In addition, he also indicates that 
PMS may not serve a functional role in preventing migration of 
polymorphs but that another mechanism might be responsable for 
preventing the response of these cells to the soluble mediators 
of inflammation.
Parrott et al (65) stress the importance of T cells in in­
duction and expression of contact sensitivity in mice. According to 
de Sousa and Fachet (29), cortisone administered prior to a sen­
sitizing dose of oxazolone to the ear skin does not eliminate T 
cells in the draining lymph node but does prohibit transformation 
of these lymphocytes. When cortisone is administered after 
sensitization, transformation of T cells occurs normally, and the 
large pyroninophilic blast cells are not affected. Therefore, these 
investigators suggest that the value of cortisone as an immuno­
suppressive agent of contact sensitivity depends upon time and the 
dose of drug that will impair T cell transformation in the draining 
lymph node. They concede, however, that the impairment may be due 
to inhibition of polymorph and macrophage infiltration at the site 
of oxazolone application. Cortisone may also prevent antigen release
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from epidermal cells or antigen transport to the - draining lymph node. 
Less work has been done on the effects of steroids on humoral 
immunity. In general, antibody production is inhibited if cortisone 
is administered prior to antigenic stimulation. For example;
Claman (23) proposes that B lymphocytes are steroid-sensitive prior 
to contact with antigen but become steroid-resistant following 
differentiation into committed B cells. Elliott and Sinclair (32) 
show that both 198 and 78 antibody are maximally suppressed when 
cortisone is given three to four days prior to sheep red blood cells. 
However, only 78 antibody is suppressed when cortisone is given after 
the antigen. A striking decrease in the peripheral lymphocyte pool 
also occurs during suppression of the antibody response. Although 
the necessity of circulating lymphocytes for expression of humoral 
immunity is well established (44), defects of antigen trapping and 
processing by macrophages, and antigen retention in lymphoid organs 
should not be overlooked as possible causes of decreased antibody 
levels. As shown by Petranyi et al (69) induction of memory and 
synthesis of ?S antibody appears more susceptible to a single large 
dose of cortisone. However, when cortisone is given from five days 
prior to antigen to the day of antigen, enhanced 198 antibody is 
apparent during 78 suppression. As a possible explanation they 
suggest that cortisone acts preferentially on the antigen-sensitive 
precursor cells. Since there aæe I5 times less ^  precursor cells 
than 19s cells in the bone marrow, this may explain the pronounced 
78 antibody suppression. Also 78 feedback-inhibition of 198 
antibody production may allow for the enhanced IgH production.
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According to Cohen and Claman (2?)§ the B cell precursors 
are more susceptible to suppression than are the helper T cells. 
Spleens of hydrocortisone-treated mice are deficient in antibody- 
forming cells, and immunocompetence may be restored by repopu­
lating the circulatory system of these mice with bone marrow but 
not with thymus cells. These researchers suggest that antibody- 
forming precursor cells in the bone marrow and the committed B 
cells are corticosteroid-resistant, while immunosuppression of 
the humoral response occurs at the level of the antigen-reactive 
B cell.
In contrast to other data, Butler (l?) reports a steroid- 
induced decrease in ongoing IgG synthesis in humans. He hypothe­
sizes that the drug inhibits the committed plasma cell and does 
not affect induction of primary or secondary antibody responses.
Another possible explanation of corticoid immunosuppression 
involves redistribution of circulating lymphocytes into other body 
compartments or arrest of lymphocyte recirculation rather than 
corticoid-induced lymphocyte alteration. Fauci (35) demon­
strates the accumulation in the bone marrow of functionally mature 
lymphocytes bearing T and B cell markers following steroid treat­
ment in guinea pigs. A similar effect is seen by Cohen (26) 
using mice and by Yu et al (108) using human volunteers.
Azathionrine
Azathioprine is used extensively in the treatment of patients 
undergoing or^n transplantation or having autoimmune disease. This 
drug is an imidazole derivative of 6-MP and is not immunosuppressive
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until it undergoes cleavage by sulfhydral compounds to release 
6-MP. Depletion of sulfhydral or amine groups during the formation 
of 6-MP may contribute to the immunosuppressive effects of azathio­
prine. The drug is broken down to its active form by eirythrocytes 
and white blood cells and has a serum half-life of about four hours (31),
Immunosuppressive effects of azathioprine on the cellular 
immune responses vary considerably with species, antigen and dosage 
although cellular immunity is not generally depressed. For example, 
human volunteers receiving low doses of azathioprine elicit normal 
induction and expression of DK to simple chemicals such as poison 
ivy allergen, dinitrochlorobenzene (DNCB) (52), and keyhole limpet 
hemocyanin (9^). The Ki response to DNCB in drug-treated guinea 
pigs is not suppressed (53)• On the other hand, the DH response 
to tuberculin, diphtheria toxoid and serum albumin is reduced or 
delayed in a variety of animals treated with this agent (77).
Multiple dose azathioprine therapy prolongs allogeneic skin graft 
survival in rats (79), suggesting suppression of the cellular 
immune response. In general^suppression of the graft rejection 
mechanism is more effective when the drug is administered following 
antigenic stimulation. From all of these data it appears that DH 
to simple chemicals is more difficult to suppress.
Poulter et al (70) report reduction in thymic weight and in 
numbers of lymphoid cells bearing theta antigen in mice treated 
with azathioprine. The population of theta-positive cells is depleted 
for three to six days following drug treatment. As in the studies 
using cortisone, T lymphocytes in the thymus cortex are azathioprine-
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sensitive while the T cells of the thymus medulla are resistant.
These authors suggest that azathioprine either deplete certain 
populations of lymphocytes or alters the antigenicity of the 
antigen—reactive T cells. Bach and Dardenne (5) note a selective 
suppression by azathioprine of the thymus-derived rosette forming 
cells. The ability of lymphocytes to form rosettes Is an iri vitro 
assay for detection of cells bearing theta antigen (6). The 
Incorporation of trltlated thymidine Into mixed lymphocyte cultures 
Is decreased when the drug Is Introduced Into the cultures during 
the first 24 hours (4), Indicating that this agent may alter 
antigen recognition during the early phase of Immune Induction.
Using labeled lymphocytes to observe lymphoid cell migration In 
mice, other Investigators find no evidence of cytolytic activity 
by azathioprine (38). Although the drug Is most effective against 
cells actively synthesizing DNA (103), Fournier et al (38) show that 
cell proliferation Is not suppressed, since lymphocyte migration 
does not Involve proliferation. Suppression of migration of lymphoid 
cells to the lymph nodes suggests that azathioprine selectively affects 
the short-lived recirculating T lymphocytes (58). The Inductive 
phase of the Immune response Is apparently more susceptible to sup­
pression since drug-treated mice acquire resistance to Listeria 
monocytogenes following the passive transfer of Immune lymphoid 
cells (97). Although the mechanism of azathioprine-Induced Immuno­
suppression Is still unclear, a membrane change Involving the anti­
gen receptors probably offers the most reasonable explanation.
In contrast, other Investigators (48) Indicate no reduction
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of rosette forming T cells, casting some doubt on the assumption 
of azathloprlne-lnduced alteration of lymphocyte antigenicity.
Azathioprine may also suppress the primary antibody response.
By using a multiple dose regimen, Santos and Owens (78) report a 
depression of the antibody response to sheep red blood cells when 
drug treatment Is begun one, two, or three days prior to antigen 
administration or four days following the antigen. However, 
maximum suppression occurs idien therapy starts on the second day 
prior to an Injection of sheep red blood cells. In addition, the 
suppression Is specific since restlmulatlon with the same antigen 
elicits no antibody response,but a primary response to a different 
antigen Is mounted. This may Indicate an Inability of committed 
T cells to function as helper cells In antibody production.
Selective suppression of 7S antibody occurs with prolonged or 
enhanced synthesis of 19S antibody, suggesting that azathioprine 
may function at the level of the mechanism resulting In the switch 
from an IgM to an IgG-produclng B cell (52, 9^). Occasionally 
enhanced antibody production Is noted In azathioprine-treated 
subjects (22, 9^). If azathioprine Is cytotoxic to lymjdiold cells, 
nucleic acid may be released when the cells lyse. Nucleic acids 
are absorbed by living cells and stimulate cell division and protein 
synthesis (8). Therefore, Immature lymphocytes may Incorporate 
the nucleic acid and be transformed Into antigen-reactive cells.
Azathioprine has little effect on the secondary antibody 
response Indicating that memory cells are resistant to suppression 
by this drug (106).
Several workers also suggest that azathioprine may exert
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an anti-inflammatory action. Borel and Schwartz (15) note 
suppression of the passive Arthus reaction, and Page and Condie (64) 
indicate that neutrophils appears at the inflammatory site but normal 
migration of lymphocytes does not follow. Perhaps chemotactic 
substances are not produced by the neutrophils, or mononuclear 
cells may be either destroyed or unresponsive.
Niridazole
Niridazole is a drug used in the treatment of helminthic in­
fections such as schistosomiasis. Mahmoud et al (35) report that 
a sin^e low dose of niridazole suppresses granuloma formation 
around Schistosoma mansoni eggs in infected mice. Repeated daily 
doses prolong allograft survival in mice when drug treatment is 
begun either before or after grafting. Interpretation of these 
results suggests that niridazole therapy produces prolonged sup­
pression of cellular immunity. Consequently, when the granulo­
matous response is decreased, eggs mature and hatch, thus facili­
tating the extraction of adult worms. Niridazole is converted 
in vitro to water soluble metabolites which bind to serum proteins, 
and this conversion may account for the extended suppression (33). 
More recently, Daniels et al (28) report that a niridazole meta­
bolite found in serum suppresses the DH response of guinea pigs 
sensitized with o-chlorebenzoyl-bovine gamma ^obulin. This 
metabolite prevents MIF production by lymphocytes but does not 
affect the response of macrophages to preformed MIF, lymphocyte 
incorporation of tritiated thymidine is unaffected in niridazole- 
treated guinea pigs. An earlier study by Mousa et al (62) is
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contzadlctive« In that they find repeated injections of a h i ^  dose 
of niridazole do not alter established schistosome Infections. However, 
the therapeutic value of niridazole is increased when the drug Is 
given pirior to infection.
Decreased bone marrow and white blood cell counts and increased 
susceptibility to infection axe not noted following treatment with 
niridazole (41, 86),
The influence of this drug on humoral immunity has not been 
extensively studied, but Pelley et al (6?) indicate that repeated 
doses of niridazole suppress antibody production for a short 
duration. Although the mechanism of action of niridazole is not 
understood, several investigators (72) suggest that suppression of 
nonspecific inflammatory reactions is involved.
Methotrexate
Methotrexate (amethopterin) is an antimetabolite ihich functions 
by competing with folic acid for the enzyme dihydrofolate reductase. 
Thus, DNA synthesis is impaired by blocking the major pathway 
leading to thymidine formation (66). The drug is excreted or 
metabolized within four hours after administration, but a threshold 
amount of the metabolites may persist for up to three weeks in tissues 
containing hi^i concentrations of folic acid (37).
In some cases methotrexate prevents development of DH. For 
example, contact sensitivity to DNCB in man (59) and to PPD in 
guinea pigs (107) are suppressed. However, this drug apparently 
does not reverse positive skin tests for established DH (47). 
Methotrexate does not prevent the development of iramunoblasts in
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lymph nodes following exposure to contact sensitivity agents as 
incorporation of tritiated thymidine occurs normally (30).
Inhibition of induction of Mi seems to occur at the level of the 
small lymphocytes which develop from immunoblasts. However, Kessel 
et al (50) report that normal and leukemic small lymphocytes are 
methotrexate-resistant, but granulocytes take up the drug. Further­
more, a single dose of the agent has no effect on skin graft survival 
in rats, but multiple doses suppress graft rejection *Aien drug therapy 
is initiated five to seven days after grafting (79). Methotrexate 
has no effect on the established resistance to the intracellular 
parasite Listeria monocytogenes. indicating that the suppression is 
not directed at macrophages (98).
Methotrexate is more effective in suppressing humoral than 
cellular immunity. Administration of multiple doses of the drug 
starting one or two days prior to injection with sheep red blood 
cells significantly prolongs primary antibody induction and sup­
presses the peak titer (78). The 7S antibody response is selectively 
suppressed when methotrexate is given from two days before to two 
days after the antigen (80), With peripheral blood mixed lymphocyte 
cultures, tritiated thymidine incorporation is inhibited up to four 
days after beginning the culture (4), suggesting a possible effect 
on proliferation of both T and B cells. When the drug is given four 
to seven days prior to injection of the antigen, immunity is actually 
enhanced as noted by marked lymphoid hyperplasia (98). Althou^ 
the mechanism of enhancement is unclear, this phenomenon implies 
that inadequate immunosuppressive therapy may in fact enhance immune 
responses, Maley and Maley (57) suggest that following methotrexate
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treatment, an increase in thymidylate synthetase, an enzyme necessary 
for the conversion of deoxyuridylate to deoxythymidylate, may 
account for the enhanced immunity by actually stimulating cell 
proliferation.
Overview on the Effects by these Four Agents
Data obtained from the cortisone studies in this investi­
gation are in agreement with previous results indicating that both
cellular and humoral immunity are suppressed. According to de Sousa
and Fachet (29), transformation of committed T cells is prevented 
when cortisone is given prior to a sensitizing dose of oxazolone, 
but DH develops normally when cortisone is given after T cell 
transformation is initiated. In this study transformation of 
committed T cells is inhibited when cortisone is administered from 
zero to four days prior to oxazolone sensitization. Drug treatment 
at earlier times allows development of the DH response in four days 
as expected (24). However, as evidenced by the experiment con­
cerning the effect of cortisone on the afferent arm of the DH re­
sponse, uncommitted T cells are not affected by cortisone and 
undergo normal transformation after a sensitizing dose of oxazolone 
to give maximum expression of DH in four days. Therefore, this 
study suggests that cortisone exerts differential suppression on the 
population of committed T cells. With this in mind, cortisone 
suppression of macrophage function seems doubtful since macrophages 
are involved in both induction and expression of DH, Cortisone- 
induced alteration of antigen recognition offers the most probable 
explanation of the mechanism of action of this drug. Studies
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using passive transfer of sensitized cells would aid in understanding 
the mechanism.
The effects of cortisone on humoral immunity are in partial 
agreement with this speculation. Previous investi^tors note that 
cortisone suppresses blastogenesis to the T-cell mitogen PHA but 
not to the B-cell mitogen pokeweed (103). Similarly, suppression 
of the antibody response to the T-cell-dependent red blood cell 
antigen is more pronounced than suppression of the response to the 
T-cell-independent LPS antigen. Again, an alteration in antigen 
recognition by T cells is suggested, but in this case, the 
uncommitted T cells are involved.
According to the literature, azathioprine and niridazole also 
suppzress cellular immunity. Suppression of the established DH response 
by azathioprine from two to six days following the drug administration 
corresponds with the absence of theta-bearing T cells noted by 
Poulter et al (?0) during this time. Azathioprine is metabolized 
and excreted rapidly. Thus, the action of this drug on only a 
small percentage of -Uie committed T cells may explain the nominal 
suppression and rapid recovery of the DH response observed in this 
study. A single dose of niridazole also causes short-term suppression 
of the efferent arm of the DH response which is similar to the 
suppression noted with azathioprine. In both instances alteration 
of antigen recognition or cytolysis of committed T cells is im- 
lioated. The uncommitted T lymphocytes are apparently unaffected 
and may respond to antigenic stimulation following elimination of 
the drug.
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The B cell function during development of humoral immunity 
seems to be resistant to suppression by these two drugs. In fact, 
the antibody response may even be enhanced by azathioprine, A 
cytotoxic effect on lymphocytes could account for this enhancement 
by releasing free nucleic acid as described earlier (8), The 
actual mechanism of suppression by these drugs is difficult to 
assess with this study because committed T cells are examined in 
the expression of DH and uncommitted T cells are examined in the 
induction of humoral immunity,
Me-Uiotrexate apparently exerts an entirely different mechanism 
of action than the other three drugs and suppresses the B cell 
compartment of the immune response. On the basis of humoral 
immunity alone, antibody production and actual numbers of B cells 
are reduced, suggesting suppression of lymj^ocyte proliferation.
Immunosuppressive agents may act cooperatively or antago­
nistically with immunological defenses, and evidence has accumulated 
that interference with the cell-mediated or humoral immune systems 
may augment one component while depressing the other. Cyclo­
phosphamide therapy results in depression of the entire immune 
response initially but continued depression of humoral immunity 
is accompanied by potentiation of cell-mediated immunity (49). 
Conversely, sheep red blood cells and LPS antibody responses in 
Pseudomonas aeruginosa infected mice are enhanced during depression 
of contact sensitivity of oxazolone (l8), Petranyi et al (69) find 
that variations in dose and time of drug administration alter the 
antibody response and induce selective enhancement of 19S antibody.
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The T and B cells exert feedback inhibition, and circulating 
antibodies may Inhibit development of cell-mediated Immune responses 
by activating suppressor T cells (42). As a result, active T cell 
proliferation ensues. Immunosuppressive drugs may eliminate feed­
back Inhibition and suppressor cell populations, resulting in 
enhancement rather than suppression of immune responses.
Expanded knowledge of temporal effects of immunosuppressive 
drugs has important practical applications in determining drug 
regimens in transplant cases and tumor therapy. Differential 
suppression by drugs might modulate the balance between cellular 
rejection mechanisms and humoral antibody enhancement. Although 
it is difficult to make generalizations about drug treatment 
since dose, schedule, route of administration, individual variability, 
and specificity of lymphoid cell populations introduce considerable 
variation, it is reasonable to expect that rational drug management 
may modulate the immune response in a practical fashion for human 
disease treatment.
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Chapter 5 
SUMMARY
Ihe ultimate role of Immunosuppression has been to control 
undesirable immune responses without altering the essential immune 
mechanism. However, to initiate reasonable therapeutic regimens, 
the effects of Immunosuppressive drugs on the normal immune responses 
should first be determined. In this study the temporal effects of 
four drugs on primary antibody production and/or delayed hyper­
sensitivity (DH) were examined. With respect to the time of drug 
administration, results indicated that lymphoid cell differentiation 
was accompanied by changes in susceptibility to various chemical 
agents.
Hydrocortisone acetate, a corticosteroid with anti-inflam­
matory properties, suppressed both cellular and humoral immunity.
The effect of hydrocortisone on the established DH response to 
oxazolone was more prolonged and severe in comparison with the 
drug's effect on induction of the DH response, but this may be 
explained on the basis of time involved for drug catabolism. 
Induction of antibody production in treated animals indicated that 
T lymphocytes were more susceptible than B lymphocytes. Since 
unsensitized T cells, memory T cells, and B cells appeared to be 
affected by hydrocortisone, either inability of lymphocytes to 
respond to antigen or sequestration of antigen-reactive lymphocytes 
in some other body compartment was suggested.
79
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Azathioprine and niridazole suppressed the established DH response, 
but the effect did not occur immediately as with cortisone. Ibis 
suggested that an interval of drug modification was required to 
render the drugs "active”. In addition, azathioprine also caused a 
brief suppression of antibody production. Apparently drug modification 
required four days, since suppression of DH and humoral immunity 
occurred four days following drug treatment. During this interval 
antigen-sensitive lymjrfiocytes were able to differentiate and pro­
liferate. Therefore, because recovery of immune responses occurred 
promptly following elimination of drug from the system, azathioprine 
and niridazole were probably cytotoxic to the sensitized lymphocytes 
and did not inhibit cell proliferation.
Methotrexate, on the other hand, suppressed the B-cell com­
partment of the immune response. Although depression of antibody 
production was prolonged in methotrexate treated animals, suscep­
tibility to PDV infection gradually returned after catabolism of 
the drug. This suggested that methotrexate suppressed lym^^ocyte 
proliferation.
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